Read More

Chipmaker Intel Pauses Construction Of $25B Chip Plant In Israel: Report

Intel has reportedly paused its plans to build a $25-billion semiconductor facility in Israel, citing the need for flexibility in project timelines and management strategies due to evolving business conditions. This pause comes despite a significant $3.2 billion incentive from the Israeli government, aimed at strengthening the global supply chain.

FTXL

Read More

Arcutis Presents New Long-Term Data Of Roflumilast Cream 0.15% For The Treatment Of Mild To Moderate Atopic Dermatitis In Adults And Children Down To Age 6 At The Revolutionizing Alopecia Areata, Vitiligo, And Eczema Conference

Investigational roflumilast cream 0.15% showed continued improvements in the signs and symptoms of AD, including itch, through 56 weeks of treatment 66.2% of participants treated with once-daily roflumilast cream

ARQT